首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 78 毫秒
1.
采用冷冻干燥法合成了介孔羟基磷灰石(HA)/壳聚糖(CS)-万古霉素(VCM)药物释放系统复合材料, 利用SEM, XRD和FTIR等方法对材料进行了表征. 结果证实CS与HA混合复合材料具有良好的孔径和孔隙率, 万古霉素吸附于复合材料的表面和内部. 细胞毒性实验[噻唑蓝(MTT)比色法]结果表明, 材料可以促进成骨细胞增殖且具有良好的细胞相容性. 体外抑菌实验结果证实此材料可长时间抑制耐甲氧西林金葡菌(MRSA)的生长, 具有良好的抑菌和杀菌能力. 细胞黏附实验结果表明, 成骨细胞附着于材料表面增殖并通过孔道延伸. 实时聚合酶链式反应(RT-PCR)实验结果表明, 在成骨相关标志产物胶原蛋白-1(COL-1)及骨形态发生蛋白-2(BMP-2)基因上均有较高的表达, 表明材料在体外可以促进成骨细胞生长, 具有良好的成骨能力.  相似文献   

2.
采用化学-物理交联法制备了聚乙烯醇/壳聚糖/纳米羟基磷灰石(PVA/CS/n-HA)复合水凝胶材料。通过对比其含水率、拉伸强度、红外光谱和TG谱图,探讨了PVA含量及戊二醛加入量对材料性能的影响。结果表明,m(PVA)∶m(CS+n-HA)=5∶1,戊二醛质量分数为2%时,复合水凝胶材料具有较好的综合性能:含水率为82.0%、拉伸强度为2.14 MPa、断裂伸长率为343.26%;同步热分析表明,25~140℃,仅存在水分的蒸发,直至360℃材料才发生分解,说明材料的热稳定性良好;红外分析表明,CS与戊二醛发生了交联反应。  相似文献   

3.
原位沉析法制备可吸收壳聚糖/羟基磷灰石棒材   总被引:19,自引:1,他引:19  
利用原位沉析法制备出一种以壳聚糖 (Chitosan ,CS)为基体 ,羟基磷灰石 (Hydroxyapatite,HA)为填料的新颖的复合材料 ,系统研究了HA含量对复合材料的力学性能和吸水率的影响 .CS HA的弯曲强度为 6 7 8(MPa) ,弯曲模量为 3 3(GPa) ,剪切强度为 2 1 2 (MPa) ,压缩强度为 4 7 8(MPa) ,均比人的自然骨高 2~ 3倍 ,基本满足了作为骨折内固定材料的力学性能的要求 .HA加入到CS使CS HA复合材料的吸水率下降 ,有助于延缓其力学强度在湿态环境下的衰减  相似文献   

4.
原位沉析法制备磁性氧化铁羟基磷灰石/壳聚糖棒材   总被引:3,自引:0,他引:3  
首先通过化学沉淀法制备磁性氧化铁羟基磷灰石(Fe3O4/HA),然后以壳聚糖(CS)为基体,利用原位沉析法将Fe3O4/HA与CS复合,制得磁性Fe3O4/HA/CS复合材料.经XRD、粒径分布和PPMS测试,结果表明了Fe3O4/HA复合物的生成.系统研究了磁性Fe3O4/HA/CS棒材力学性能的影响因素,最终确定Fe3O4与HA质量比为3∶17,磁性Fe3O4/HA与CS质量比为9∶91时,棒材的力学性能最优,弯曲强度可达到87.0 MPa,弯曲模量1.57 GPa.  相似文献   

5.
采用化学 物理交联法制备了聚乙烯醇/壳聚糖/纳米羟基磷灰石(PVA/CS/n-HA)复合水凝胶材料。 通过对比其含水率、拉伸强度、红外光谱和TG谱图,探讨了PVA含量及戊二醛加入量对材料性能的影响。 结果表明,m(PVA)∶m(CS+n-HA)=5∶1,戊二醛质量分数为2%时,复合水凝胶材料具有较好的综合性能:含水率为82.0%、拉伸强度为2.14 MPa、断裂伸长率为343.26%;同步热分析表明,25~140 ℃,仅存在水分的蒸发,直至360 ℃材料才发生分解,说明材料的热稳定性良好;红外分析表明,CS与戊二醛发生了交联反应。  相似文献   

6.
利用原位共沉淀法合成了羟基磷灰石/壳聚糖复合吸附剂,通过扫描电镜、X射线粉末衍射、红外光谱和N2吸附-脱附曲线,研究复合前后羟基磷灰石的理化特征变化。实验结果表明与壳聚糖复合后羟基磷灰石的晶型并没有改变,只是结晶度有所降低,且复合后表面形成了不规则的凹凸结构,表面粗糙度增加。比表面积从106.75m2/g增加到127.58m2/g。复合吸附剂孔径大部分集中在10~50nm,属于介孔结构。利用Langmuir和Freundlich吸附等温方程对实验数据进行了拟合,对比相关系数R2值,Langmuir模型能更好地描述该吸附过程。复合吸附剂对氟离子的吸附符合拟二级反应动力学方程。计算了吸附热力学和动力学参数值,探讨了复合吸附剂对氟离子的吸附机理。ΔG0<0、ΔH0>0和ΔS0>0,说明复合吸附剂对氟离子的吸附是自发的、吸热的熵增过程,温度升高有利于吸附。吸附活化能(Ea)=15.03kJ·mol-1,迁移能(E)=7.639kJ·mol-1,说明该吸附过程以物理吸附为主。  相似文献   

7.
尿素共沉淀法制备纤维状羟基磷灰石/壳聚糖复合粉料   总被引:1,自引:0,他引:1  
杨洪  傅山岗 《应用化学》2005,22(1):87-0
尿素共沉淀法制备纤维状羟基磷灰石/壳聚糖复合粉料;壳聚糖; 羟基磷酸钙; 尿素共沉淀  相似文献   

8.
原位复合法制备层状结构的壳聚糖/羟基磷灰石纳米材料   总被引:21,自引:0,他引:21  
用原位复合法制备了高性能的壳聚糖/羟基磷灰石(CS/HA)纳米复合材料.用预先沉积的壳聚糖膜将含有羟基磷灰石前驱体的壳聚糖溶液与凝固液隔离,同时控制壳聚糖沉积与羟基磷灰石前驱体转化为羟基磷灰石的过程,使其缓慢且有序地进行.当pH值改变时,质子化的壳聚糖分子链在负电层诱导下有序沉积并形成层状结构与羟基磷灰石原位生成CS/HA,并实现二者分子级复合.XRD和TEM测试证实原位生成的磷酸盐是羟基磷灰石,且其颗粒长约为100nm,宽30~50nm.SEM结果表明,用原位复合法制备的材料具有层状结构,CS/HA(质量比100/5)纳米复合材料弯曲强度高达86MPa,比松质骨的高3~4倍,相当于密质骨的1/2,有望用于可承重部位的组织修复材料.  相似文献   

9.
本研究采用一种简便的方法,在室温环境下合成了片状的羟基磷灰石晶体。我们采用X射线粉末衍射、ICP和红外光谱,透射电镜和选区电子衍射对获得的样品进行了表征。根据表征的结果和现有文献的支持,我们认为壳聚糖的诱导作用下形成的羟基磷灰石纳米晶体属于单斜晶系。  相似文献   

10.
将力学性能优良的碳纳米管(CNTs)与羟基磷灰石(HA)生物陶瓷相复合,发展CNTs/HA复合材料来应用于骨组织修复领域,有望解决HA生物陶瓷力学性能的不足.通过3种不同的制备方法,即通过表面活性剂将CNTs分散在HA基体中、通过酸碱中和反应将CNTs与HA共沉淀以及通过体外浸泡在CNTs上矿化生长HA等方法来获得CNTs/HA复合材料.深入研究CNTs的表面结构和分散状态对CNTs/HA复合材料力学性能的影响.结果表明,CNTs的添加改变了HA的脆性,导致复合材料抗压力学性能得到提高.但是,由于复合材料制备方法的不同,导致CNTs在HA基体中的分散状态、表面结构的完整性以及与HA的界面结合情况不同,导致其抗压力学性能不同.其中,通过表面活性剂将CNTs分散在HA基体中而获得复合材料的抗压力学性能表现最好,而CNTs与HA通过共沉淀法所获得复合材料的抗压力学性能表现最差.  相似文献   

11.
球状多孔羟基磷灰石生物材料的制备与结构   总被引:9,自引:0,他引:9  
牛血清白蛋白;药物缓释;球状多孔羟基磷灰石生物材料的制备与结构  相似文献   

12.
利用碳酸钙作为处理模板,通过共沉淀联合水热法,制备了硒元素掺杂羟基磷灰石微球(HASe),期望硒掺杂能提高HA对溶菌酶的加载,并增强HASe微球的杀菌活性。所合成的HASe微球经SEM、TEM、DLS、XRD、FTIR和TGA测试对其理化性能进行了表征。并且利用姜黄素作为模式药物,评估了它们的药物加载及控释效能。结果发现,所合成的HASe产物为直径约1.0μm的球体,球壁粘附有许多羟基磷灰石纳米棒(长约150 nm﹑宽约20 nm)。该HASe微球对姜黄素具有高的药物加载和缓慢稳定的控释效应。其药物加载量为(88.72±0.01)mg·g~(-1),在0~159 h内仅有不到1.5 mg的姜黄素被释放,且无爆释现象。此外,还通过血液分析和细胞实验评估了HASe微球的毒性行为。与无硒HA微球相比,HASe微球的血液毒性低,对细胞损伤少,然而对骨肉瘤细胞生长却具有强的抑制作用。  相似文献   

13.
Dye and heavy metal contaminants are mainly aquatic pollutants. Although many materials and methods have been developed to remove these pollutants from water, effective and cheap materials and methods are still challenging. In this study, highly porous hydroxyapatite/graphene oxide/chitosan beads (HGC) were prepared by a facile one-step method and investigated as efficient adsorbents. The prepared beads showed a high porosity and low bulk density. SEM images indicated that the hydroxyapatite (HA) nanoparticles and graphene oxide (GO) nanosheets were well dispersed on the CTS matrix. FT-IR spectra confirmed good incorporation of the three components. The adsorption behavior of the obtained beads to methylene blue (MB) and copper ions was investigated, including the effect of the contact time, pH medium, dye/metal ion initial concentration, and recycle ability. The HGC beads showed rapid adsorption, high capacity, and easy separation and reused due to the porous characteristics of GO sheets and HA nanoparticles as well as the rich negative charges of the chitosan (CTS) matrix. The maximum sorption capacities of the HGC beads were 99.00 and 256.41 mg g−1 for MB and copper ions removal, respectively.  相似文献   

14.
Nanotechnology-based development of drug delivery systems is an attractive area of research in formulation driven R&D laboratories that makes administration of new and complex drugs feasible. It plays a significant role in the design of novel dosage forms by attributing target specific drug delivery, controlled drug release, improved, patient friendly drug regimen and lower side effects. Polysaccharides, especially chitosan, occupy an important place and are widely used in nano drug delivery systems owing to their biocompatibility and biodegradability. This review focuses on chitosan nanoparticles and envisages to provide an insight into the chemistry, properties, drug release mechanisms, preparation techniques and the vast evolving landscape of diverse applications across disease categories leading to development of better therapeutics and superior clinical outcomes. It summarizes recent advancement in the development and utility of functionalized chitosan in anticancer therapeutics, cancer immunotherapy, theranostics and multistage delivery systems.  相似文献   

15.
Antibiotics played an important role in controlling the development of enteric infection. However, the emergence of antibiotic resistance and gut dysbiosis led to a growing interest in the use of natural antimicrobial agents as alternatives for therapy and disinfection. Chitosan is a nontoxic natural antimicrobial polymer and is approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration). Chitosan and chitosan derivatives can kill microbes by neutralizing negative charges on the microbial surface. Besides, chemical modifications give chitosan derivatives better water solubility and antimicrobial property. This review gives an overview of the preparation of chitosan, its derivatives, and the conjugates with other polymers and nanoparticles with better antimicrobial properties, explains the direct and indirect mechanisms of action of chitosan, and summarizes current treatment for enteric infections as well as the role of chitosan and chitosan derivatives in the antimicrobial agents in enteric infections. Finally, we suggested future directions for further research to improve the treatment of enteric infections and to develop more useful chitosan derivatives and conjugates.  相似文献   

16.
Porous microspheres have been prepared by suspension free radical polymerization of acrylic acid (AA) in the presence of chitosan (CHI). The microspheres were characterized by FTIR and environmental SEM. The PAA content of the microspheres was estimated to be in the range 45–50 wt.‐%. The swelling degree of these particles is almost constant in the range 2 < pH < 5, but it increases considerably as the pH is raised from 5 to 10. The release profiles of microspheres loaded with meclofenamic acid (MF) were determined at pH 2, 7.4, and 10. The in vitro release of MF at different pHs was modulated by the solubility of the drug. These microcapsules are biodegradable and presented good biocompatibility and biodegradability during in vivo experiments.

ESEM microphotograph of the porous PAA/CHI microspheres.  相似文献   


17.
通过逐步沉淀反应一锅法制备了一系列不同含量的镁掺杂纳米羟基磷灰石。通过硝酸镁、硝酸钙不同的投料物质的量比调控纳米颗粒的形态和尺寸。通过透射电子显微镜(TEM)、X射线衍射(XRD)等分析手段对镁掺杂纳米羟基磷灰石进行物理化学性能表征,用MTT法评价其体外细胞毒性。研究结果表明:镁掺杂纳米羟基磷灰石呈现束状纳米纤维形态、比表面积大、细胞毒性较低;将其作为载体负载抗癌药物顺铂,具有很好的载药能力,载药量可达54%,该载药纳米颗粒还具备缓释特性(72 h释药量达到41.72%)和很好抑制癌细胞生长的效果。  相似文献   

18.
Hydrogel‐forming copolymers based on chitosan grafted with different amounts of polyacrylamide were synthesized and its swelling capacity determined in distilled water, sodium chloride solutions, as well as in buffer solutions at pH 1.2 and 8.0. The resulting products are highly efficient as hydrogel‐forming materials with swelling at equilibrium going approximately from 300 to 3 000 times the volume of the dry solid polymer in all the investigated media. The products, different to usual hydrogels, swells considerably more and quickly in electrolyte‐containing solutions compared to in distilled water. This has been attributed to their structure that contains non‐ionic polyacrylamide macromolecules grafted onto the trunk polymer chitosan, which is cationic in nature. In‐vitro drug‐release behavior of formulations containing grafted copolymers have been tested using theophylline as a water‐soluble drug and the results were compared with similar formulations containing unmodified chitosan. It was found that tablets based on formulations containing grafted chitosan show higher erosion and swelling compared with those of the matrix based on unmodified chitosan, leading to a higher fraction of theophylline released. It can be concluded that formulations based on the synthesized copolymers are potentially useful for fluid absorbency and as prolonged drug‐release matrices.

The swelling of one of the hydrogels studied here.  相似文献   


19.
通过逐步沉淀反应一锅法制备了一系列不同含量的镁掺杂纳米羟基磷灰石。通过硝酸镁、硝酸钙不同的投料物质的量比调控纳米颗粒的形态和尺寸。通过透射电子显微镜(TEM)、X射线衍射(XRD)等分析手段对镁掺杂纳米羟基磷灰石进行物理化学性能表征,用MTT法评价其体外细胞毒性。研究结果表明:镁掺杂纳米羟基磷灰石呈现束状纳米纤维形态、比表面积大、细胞毒性较低;将其作为载体负载抗癌药物顺铂,具有很好的载药能力,载药量可达54%,该载药纳米颗粒还具备缓释特性(72 h释药量达到41.72%)和很好抑制癌细胞生长的效果。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号